Evrim Umut

Dr. Evrim Umut

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
EUEvrim Umut
Evrim Umut
MCMustafa Coşkun
Mustafa Coşkun
FPFrancesco Pineider
Francesco Pineider
DBDebora Berti
Debora Berti
HGHakan Güngüneş
Hakan Güngüneş

1 October 2020 in Polymer Testing
Verified
Journal Article
Closed access
ÖMÖmer Bahadır Mergen
Ömer Bahadır Mergen
EUEvrim Umut
Evrim Umut
EAErtan Arda
Ertan Arda
SKSelim Kara
Selim Kara

1 August 2012 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
EUEvrim Umut
Evrim Umut
Francesco PineiderFrancesco Pineider
Francesco Pineider
PAPaolo Arosio
Paolo Arosio
CSClaudio Sangregorio
Claudio Sangregorio
MCM. Corti
M. Corti
PGPaolo Ghigna
Paolo Ghigna

22 May 2013
Verified
Book Chapter
Open access
PDF file
EUEvrim Umut
Evrim Umut
Surface Modification of Nanoparticles Used in Biomedical Applications | InTechOpen, Published on: 2013-05-22. Authors: Evrim Umut

26 April 2018 in Physical Chemistry Chemical Physics
Verified
Journal Article
Open access
PDF file
DKDanuta Kruk
Danuta Kruk
EUEvrim Umut
Evrim Umut
EMElżbieta Masiewicz
Elżbieta Masiewicz
CSCarina Sampl
Carina Sampl
Roland FischerRoland Fischer
Roland Fischer
HSHermann Scharfetter
Hermann Scharfetter
209Bi containing species have the potential to become novel contrast agents for MRI.

25 January 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SSSelin S. Suner
Selin S. Suner
Mehtap SahinerMehtap Sahiner
Mehtap Sahiner
SDSahin Demirci
Sahin Demirci
EUEvrim Umut
Evrim Umut
Nurettin SahinerNurettin Sahiner
Nurettin Sahiner
Fluorescent graphitic carbon nitride (g-C3N4) doped with various heteroatoms, such as B, P, and S, named Bg-C3N4, Pg-C3N4, and Sg-C3N4, were synthesized with variable band-gap values as diagnostic materials. Furthermore, they were embedded within hyaluronic acid (HA) microgels as g-C3N4@HA microgel composites. The g-C3N4@HA microgels had a 0.5–20 μm size range that is suitable for intravenous administration. Bare g-C3N4 showed excellent fluorescence ability with 360 nm excitation wavelength and 410–460 emission wavelengths for possible cell imaging application of g-C3N4@HA microgel composites as diagnostic agents. The g-C3N4@HA-based microgels were non-hemolytic, and no clotting effects on blood cells or cell toxicity on fibroblasts were observed at 1000 μg/mL concentration. In addition, approximately 70% cell viability for SKMEL-30 melanoma cells was seen with Sg-C3N4 and its HA microgel composites. The prepared g-C3N4@HA and Sg-C3N4@HA microgels were used in cell imaging because of their excellent penetration capability for healthy fibroblasts. Furthermore, g-C3N4-based materials did not interact with malignant cells, but their HA microgel composites had significant penetration capability linked to the binding function of HA with the cancerous cells. Flow cytometry analysis revealed that g-C3N4 and g-C3N4@HA microgel composites did not interfere with the viability of healthy fibroblast cells and provided fluorescence imaging without any staining while significantly decreasing the viability of cancerous cells. Overall, heteroatom-doped g-C3N4@HA microgel composites, especially Sg-C3N4@HA microgels, can be safely used as multifunctional theragnostic agents for both diagnostic as well as target and treatment purposes in cancer therapy because of their fluorescent nature.